104 related articles for article (PubMed ID: 17342334)
1. Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells.
Fernandez-Cobo M; Zammarchi F; Mandeli J; Holland JF; Pogo BG
Oncol Rep; 2007 Apr; 17(4):903-7. PubMed ID: 17342334
[TBL] [Abstract][Full Text] [Related]
2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
3. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
5. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
6. WNT5A expression in human breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2005; 25(2A):731-4. PubMed ID: 15868903
[TBL] [Abstract][Full Text] [Related]
7. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
[TBL] [Abstract][Full Text] [Related]
8. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.
Wang Q; Symes AJ; Kane CA; Freeman A; Nariculam J; Munson P; Thrasivoulou C; Masters JR; Ahmed A
PLoS One; 2010 May; 5(5):e10456. PubMed ID: 20454608
[TBL] [Abstract][Full Text] [Related]
9. Mineral-enriched deep-sea water inhibits the metastatic potential of human breast cancer cell lines.
Kim S; Chun SY; Lee DH; Lee KS; Nam KS
Int J Oncol; 2013 Nov; 43(5):1691-700. PubMed ID: 24008507
[TBL] [Abstract][Full Text] [Related]
10. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
11. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
12. Frequent up-regulation of WNT5A mRNA in primary gastric cancer.
Saitoh T; Mine T; Katoh M
Int J Mol Med; 2002 May; 9(5):515-9. PubMed ID: 11956659
[TBL] [Abstract][Full Text] [Related]
13. WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
Jiang W; Crossman DK; Mitchell EH; Sohn P; Crowley MR; Serra R
PLoS One; 2013; 8(3):e58329. PubMed ID: 23484019
[TBL] [Abstract][Full Text] [Related]
14. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells.
Saitoh T; Katoh M
Int J Mol Med; 2002 Sep; 10(3):345-9. PubMed ID: 12165812
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
[TBL] [Abstract][Full Text] [Related]
17. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.
Nygren MK; Døsen G; Hystad ME; Stubberud H; Funderud S; Rian E
Br J Haematol; 2007 Feb; 136(3):400-13. PubMed ID: 17156404
[TBL] [Abstract][Full Text] [Related]
18. WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer.
Wend P; Runke S; Wend K; Anchondo B; Yesayan M; Jardon M; Hardie N; Loddenkemper C; Ulasov I; Lesniak MS; Wolsky R; Bentolila LA; Grant SG; Elashoff D; Lehr S; Latimer JJ; Bose S; Sattar H; Krum SA; Miranda-Carboni GA
EMBO Mol Med; 2013 Feb; 5(2):264-79. PubMed ID: 23307470
[TBL] [Abstract][Full Text] [Related]
19. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
MacMillan CD; Leong HS; Dales DW; Robertson AE; Lewis JD; Chambers AF; Tuck AB
Sci Rep; 2014 Sep; 4():6315. PubMed ID: 25204426
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a as an effector of TGFβ in mammary development and cancer.
Serra R; Easter SL; Jiang W; Baxley SE
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):157-67. PubMed ID: 21416313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]